Compositions comprising bacterial strains

Described are lyophilised compositions comprising Eubacterium contortum for use in the treatment or prevention of inflammatory or autoimmune diseases mediated by the Th17 pathway. The disease is preferably uveitis, asthma, rheumatoid arthritis or multiple sclerosis. The Eubacterium contortum may be...

Full description

Saved in:
Bibliographic Details
Main Authors Suaad Ahmed, Grainne Claire Lennon, Imke Elisabeth Mulder, Seanin Marie McCluskey, Amy Beth Holt
Format Patent
LanguageEnglish
Published 05.01.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Described are lyophilised compositions comprising Eubacterium contortum for use in the treatment or prevention of inflammatory or autoimmune diseases mediated by the Th17 pathway. The disease is preferably uveitis, asthma, rheumatoid arthritis or multiple sclerosis. The Eubacterium contortum may be strain MRX050.
Bibliography:Application Number: GB20210008591